title: Ventricular arrhythmias and mortality associated with isoflurane and sevoflurane in a porcine model of myocardial infarction.
abstract: Ischemia of the myocardium can lead to reversible or irreversible injury depending on the severity and duration of the preceding ischemia. Here we compared sevoflurane and isoflurane with particular reference to their hemodynamic effects and ability to modify the effects of acute severe myocardial ischemia and reperfusion on ventricular arrhythmias and mortality in a porcine model of myocardial infarction. Female Large White pigs were premedicated with ketamine, midazolam, and atropine. Propofol was given intravenously for the anesthetic induction, and anesthesia was maintained with isoflurane or sevoflurane. Endovascular, fluoroscopy-guided, coronary procedures were performed to occlude the midleft anterior descending artery by using a coronary angioplasty balloon. After 75 min, the balloon catheter system was withdrawn and the presence of adequate reperfusion flow was verified. The pigs were followed for 2 mo, and overall mortality rate was calculated. The isoflurane group showed lower arterial pressure throughout the procedure, with the difference reaching statistical significance after induction of myocardial ischemia. The ventricular fibrillation rate was higher in isoflurane group (81.3%) than the sevoflurane group (51.7%; relative risk, 1.57 [1.03 to 2.4]). Overall survival was lower in the isoflurane group (75%) than the sevoflurane group (96.4%). In conclusion, in this porcine model of myocardial ischemia and reperfusion, sevoflurane was associated with higher hemodynamic stability and fewer ventricular arrhythmias and mortality than was isoflurane.
authors.affiliation: Fundación Investigación Sanitaria en León, and Institute of Biomedicine, University of León, León, Spain. mregf@unileon.es
authors.forename: Marta
authors.initials: M
authors.lastname: Regueiro-Purriños
authors.forename: Felipe
authors.initials: F
authors.lastname: Fernández-Vázquez
authors.forename: Armando Perez
authors.initials: AP
authors.lastname: de Prado
authors.forename: Jose R
authors.initials: JR
authors.lastname: Altónaga
authors.forename: Carlos
authors.initials: C
authors.lastname: Cuellas-Ramón
authors.forename: Jose M
authors.initials: JM
authors.lastname: Ajenjo-Silverio
authors.forename: Asuncion
authors.initials: A
authors.lastname: Orden
authors.forename: Jose M
authors.initials: JM
authors.lastname: Gonzalo-Orden
mesh_terms: D018685:Anesthetics, Inhalation / Q000627:therapeutic use*; D000827:Animal Welfare; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000150:complications / Q000401:mortality / Q000517:prevention & control / Q000662:veterinary*; D004195:Disease Models, Animal; D005260:Female; D007530:Isoflurane / Q000627:therapeutic use*; D008738:Methyl Ethers / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000150:complications*; D015428:Myocardial Reperfusion Injury / Q000150:complications / Q000401:mortality / Q000517:prevention & control / Q000662:veterinary*; D000077149:Sevoflurane; D015996:Survival Rate; D013552:Swine; D013553:Swine Diseases / Q000401:mortality / Q000517:prevention & control*
chemical_list: D018685:Anesthetics, Inhalation; D008738:Methyl Ethers; D000077149:Sevoflurane; D007530:Isoflurane